These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38552916)

  • 21. The effect of premenstrual dysphoric disorder and menstrual cycle phase on brain activity during response inhibition.
    Bannbers E; Gingnell M; Engman J; Morell A; Comasco E; Kask K; Garavan H; Wikström J; Sundström Poromaa I
    J Affect Disord; 2012 Dec; 142(1-3):347-50. PubMed ID: 22840469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in mood, cognitive performance and appetite in the late luteal and follicular phases of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorder).
    Reed SC; Levin FR; Evans SM
    Horm Behav; 2008 Jun; 54(1):185-93. PubMed ID: 18413151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
    Sundström-Poromaa I; Comasco E
    CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 26. Emotional fronto-cingulate cortex activation and brain derived neurotrophic factor polymorphism in premenstrual dysphoric disorder.
    Comasco E; Hahn A; Ganger S; Gingnell M; Bannbers E; Oreland L; Wikström J; Epperson CN; Lanzenberger R; Sundström-Poromaa I
    Hum Brain Mapp; 2014 Sep; 35(9):4450-8. PubMed ID: 24615932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in Serotonin Transporter Binding in Patients With Premenstrual Dysphoric Disorder Across the Menstrual Cycle: A Case-Control Longitudinal Neuroreceptor Ligand Positron Emission Tomography Imaging Study.
    Sacher J; Zsido RG; Barth C; Zientek F; Rullmann M; Luthardt J; Patt M; Becker GA; Rusjan P; Witte AV; Regenthal R; Koushik A; Kratzsch J; Decker B; Jogschies P; Villringer A; Hesse S; Sabri O
    Biol Psychiatry; 2023 Jun; 93(12):1081-1088. PubMed ID: 36997451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered visual cortex excitability in premenstrual dysphoric disorder: Evidence from magnetoencephalographic gamma oscillations and perceptual suppression.
    Manyukhina VO; Orekhova EV; Prokofyev AO; Obukhova TS; Stroganova TA
    PLoS One; 2022; 17(12):e0279868. PubMed ID: 36584199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.
    Eisenlohr-Moul TA; Kaiser G; Weise C; Schmalenberger KM; Kiesner J; Ditzen B; Kleinstäuber M
    Psychol Med; 2020 Apr; 50(6):964-972. PubMed ID: 31010447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.
    Epperson CN; Pittman B; Czarkowski KA; Stiklus S; Krystal JH; Grillon C
    Neuropsychopharmacology; 2007 Oct; 32(10):2190-8. PubMed ID: 17314917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. State and trait cognitions differentially affect cyclicity of mood and cortisol in individuals with and without premenstrual dysphoric disorder.
    Nayman S; Schricker IF; Reinhard I; Dreer JK; Richter AS; Kuehner C
    J Psychopathol Clin Sci; 2024 May; 133(4):309-320. PubMed ID: 38635192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention, response inhibition, impulsivity, and decision-making within luteal phase in women with premenstrual dysphoric disorder.
    Yen JY; Lin PC; Hsu CJ; Lin C; Chen IJ; Ko CH
    Arch Womens Ment Health; 2023 Jun; 26(3):321-330. PubMed ID: 37010619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum brain-derived neurotrophic factor differences between the luteal and follicular phases in premenstrual dysphoric disorder.
    Oral E; Kirkan TS; Yildirim A; Kotan Z; Cansever Z; Ozcan H; Aliyev E; Gulec M
    Gen Hosp Psychiatry; 2015; 37(3):266-72. PubMed ID: 25799087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pilot investigation of the circadian plasma melatonin rhythm across the menstrual cycle in a small group of women with premenstrual dysphoric disorder.
    Shechter A; Lespérance P; Ng Ying Kin NM; Boivin DB
    PLoS One; 2012; 7(12):e51929. PubMed ID: 23284821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menstrual Cycle and the Prevalence of Premenstrual Syndrome/Premenstrual Dysphoric Disorder in Adolescent Athletes.
    Czajkowska M; Drosdzol-Cop A; Gałązka I; Naworska B; Skrzypulec-Plinta V
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):492-8. PubMed ID: 26233292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.